Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

11 Apr 2019 07:00

RNS Number : 8235V
Polar Capital Holdings PLC
11 April 2019
Β 

Β 

11 April 2019 Polar Capital Holdings plc

AUM Update

Β 

Β 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its assets under management ("AUM") for the financial year to 31 March 2019.

Β 

Group AUMΒ (unaudited)

Β 

Polar Capital reports that as at 31 March 2019 its AUM were Β£13.8bn compared to Β£12.0bn at the end of March 2018, an increase of 15% over the year.

Β 

AUM movement in twelve months to 31 March 2019

Long-only

funds

Alternative funds

Total

AUM at

1 April 2018

Β£10,812m

Β£1,168m

Β£11,980m

Net subscriptions

Β£427m

Β£129m

Β£556m

Market movement

and performance

Β£1,290m

Β£9m

Β£1,299m

Total AUM at

31 March 2019

Β£12,529m

Β£1,306m

Β£13,835m

Β 

Β 

Β 

Comment

Β 

While the Group reports AUM at a record year-end high of Β£13.8bn, an increase of Β£1.8bn over the financial year, over the past twelve months we have experienced material fluctuations in the Group's AUM. Before the market sell-off in October, AUM reached an all time high of Β£14.7bn at the end of the first half in September but following the market correction in the final calendar quarter AUM declined to Β£12.7bn as at 31 December 2018. The strong market recovery in the recent quarter lifted AUM by Β£1.1bn to Β£13.8bn.

Β 

During the financial year, net inflows amounted to Β£556m as a result of positive net inflows in the first half of Β£932m followed by net outflows of Β£286m in the December quarter and a significantly reduced rate of net outflows of Β£90m in the recent quarter to 31 March 2019. Net flows in April have to date been positive.

Β 

Despite the market volatility over the second half, the Group's funds have performed well resulting in a record year for net performance fee profits of Β£23.6m which crystallised on 31 December 2018.

Β 

Gavin Rochussen, Chief Executive, commented:

Β 

"Polar Capital has had a year of two halves with strong growth in AUM through net inflows, performance and markets in the first half followed by reduced risk appetite for our specialist fund strategies following the global sell-off and market correction in October and December of 2018. Net flows have stabilised and funds have continued to perform in line with our expectation, with 76% of the Group's AUM ahead of their benchmarks annualised over three years to 31 March 2019. In the last quarter, the majority of AUM and fund strategies outperformed their respective benchmarks."

Β 

"With a diverse range of actively managed specialist fund strategies, Polar Capital is positioned to continue performing for its clients and has capacity to attract additional net inflows. Market volatility is expected to remain as political tensions continue and as Brexit, with an unpredictable outcome, runs its course."

Β 

Polar Capital will announce its results for the financial year to 31 March 2019 on 24 June 2019.

Β 

For further information please contact:

Β 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (COO)

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

+44 (0)20 7260 1000

Β 

Β 

Peel Hunt LLP - Joint Broker

Guy Wiehahn

Β 

+44 (0)20 7418 8893

Β 

Camarco

Ed Gascoigne-Pees

Β 

Β 

+44 (0)20 3757 4984

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCEAKLEFFKNEFF
Date   Source Headline
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.